Cost and time for clinical development constitute more than 70% of total development of any drug! Small – mid scale biopharma are known for their innovative approaches, agility and faster developments. However, clinical development has always been one step too important, yet too hard for them. There are ways to overcome these challenges and optimize […]

Read More →

Do you know any product segment, where one does not get to encounter Chinese products? Well, hardly any. It has been the focus of Chinese government for the past several decades to dominate various industrial sectors, including pharmaceuticals. While, China has been the big production factory for generic drugs and API ingredients for many years, […]

Read More →

Rare disease drug development is a rapidly expanding field with growing pressure for getting more orphan drug approved to treat rare diseases. There is a vast consensus among patients, health care bodies, governments etc. to expedite drug development in this field. Some wonderful numbers that attest to growing interest in rare diseases and orphan drugs […]

Read More →

Over a million people are currently living with TB in Indonesia, making up more than 10% of the world’s TB burden. Of the estimated 32 000 new cases of drug-resistant TB in the country, only about a third of these cases were detected. In a country with a high malaria burden, less than 1% of […]

Read More →

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or motor neuron disease (MND), is a fatal disease of the nervous system, characterized by progressive muscle weakness resulting in paralysis. Symptoms include stiff muscles, muscle twitching, and gradually worsening weakness due to muscles decreasing in size. In ALS, moton neurons controlling the voluntary muscles, […]

Read More →

The United States has consistently emerged as a leading site for clinical research. Clinicaltrials.gov registry, which serves as an effective reference to see clinical trials conducted worldwide, provides an interesting statistics regarding U.S. clinical trials. Clinical trials statistics in the U.S. A glimpse into the studies registered between 2011 and 2013 and further between 2014 […]

Read More →

Psychiatric illnesses represent one of the most important segment for drug development in last several decades1. They are among the leading causes of ill-health and disability worldwide with about 450 million people currently suffering2. One in 5 adults experiences a mental health condition every year3. Drug Development in Psychiatry No wonder, leading pharmaceutical companies have […]

Read More →

With clinical research industry taking more globalized form than local, any development has a global impact. So, when four major organizations of an Industry goes through transformations, dynamics of the industry changes. This is what is happening currently with Clinical Research Industry as well. Geographically, the market is focused primarily in the north america, which […]

Read More →

From that first randomized clinical trial on board HMS Salisbury in 1747, we’ve come a long way! Still, there is more to be done. More horizons are to be explored, more medicines to be developed, and more patients to be cured. Let’s celebrate May 20, 2017 as a new beginning to even better, even faster […]

Read More →